Bill Text — Jun 4, 2012
This bill’s text for status Placed on Calendar in the Senate (Jun 4, 2012) is now available.
Mar 29, 2012
112th Congress, 2011–2013
This bill was introduced on March 29, 2012, in a previous session of Congress, but was not enacted.
Representative for New Jersey's 6th congressional district
Read Text »
Last Updated: Mar 29, 2012
Length: 7 pages
To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes.
3/29/2012--Introduced.Generic Drug Application Review Fairness Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to extend from 30 to 60 months after application the period for a ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 4332”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 4332 — 112th Congress: Generic Drug Application Review Fairness Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr4332
“H.R. 4332 — 112th Congress: Generic Drug Application Review Fairness Act of 2012.” www.GovTrack.us. 2012. October 5, 2015 <https://www.govtrack.us/congress/bills/112/hr4332>
|title=H.R. 4332 (112th)
|accessdate=October 5, 2015
|author=112th Congress (2012)
|date=March 29, 2012
|quote=Generic Drug Application Review Fairness Act of 2012